ACE and systemic sclerosis: Background. To describe the methodology of astudy designed to determine whether systemic sclerosis (SSc)patients with incident scleroderma renal crisis (SRC) onangiotensin converting enzyme (ACE) inhibitors prior to the onsetof SRC have worse outcomes.